Patent ID: 8481521

Claim:
A method of treating a cell proliferative disorder, comprising: administering to a subject in need thereof a compound having the structure or a salt thereof, wherein R p is selected from —CH 2 —O—P(O)(OH) 2 , —CH 2 CH 2 —O—P(O)(OH) 2 and —CH 2 OH, in an amount effective to treat the cell proliferative disorder wherein the cell proliferative disorder is selected from B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma, B-cell prolymphocytic leukemia, lymphoplasmacytic lymphoma, splenic marginal zone B-cell lymphoma, hairy cell leukemia, plasma cell myeloma/plasmacytoma, extranodal marginal zone B-cell lymphoma of MALT type, nodal marginal zone B-cell lymphoma, follicular lymphoma, mantle-cell lymphoma, diffuse large B-cell lymphoma, mediastinal large B-cell lymphoma, primary effusion lymphoma, and Burkitt's lymphoma/Burkitt cell leukemia.